HAOHAI BIOTEC (06826) spent 1.5342 million Hong Kong dollars to repurchase 61,000 shares on December 29th.
Haohai Biotechnology (06826) announced that on December 29, 2025, the company spent 1.5342 million Hong Kong dollars to repurchase 61,000 shares, at a repurchase price of 25-25.4 Hong Kong dollars per share.
HAOHAI BIOTEC (06826) announced that the company repurchased 61,000 shares for a total of HK$1,534,200 on December 29, 2025, at a repurchase price of HK$25-25.4 per share.
On the same day, 201,950 shares of repurchased shares were cancelled.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


